Global Health

Over 100 years of Advancing Pharmacy Worldwide

Clinical research and trials in the Australia and New Zealand region offer foreign companies an opportunity to collaborate with local institutions, tap into diverse patient populations, access high-quality healthcare infrastructure, and gain regulatory approvals, enabling them to expand their market reach and accelerate the development of innovative medical interventions.

Clinical trials continued in Australia and New Zealand during lockdown, thanks to collaboration between industry and government, allowing the region to attract trials from other countries.

Preventing surgery related infections

Surgical site infections (SSI) is infection that occurs after surgery in a part of the body where the surgery took place. Surgical site infections are seen as the most common healthcare-associated infection, significantly impacting healthcare resources in the UK and across the World.

Professor Leaper speaks on needing ongoing good antibiotic stewardship to reduce the risk of antibiotic-resistant and emergent organisms. The pressures on administering antibiotics have led to tighter management and stewardship of antibiotics.

Technology to reach global health equity

Dr Terry Knapp, MD as a plastic and reconstructive plastic surgeon, has given back to medicine and global health through over 35 overseas trips as a volunteer surgeon. He is also an inventor with 16 medical device and technology patents to his name. His entrepreneurial spirit has led to founding 6 successful companies, leading to today being the Founder and Chief Medical Officer of CareSpan Health.

Health equity, in technology driven health care delivery, is determined by access to the clinician, specifically communications medical technology. CareSpan Health developed an integrated digital care ecosystem. The architecture of which became, Clinic in the Cloud.

Australia’s digital health push into new national markets

Infection rates following surgical procedure vary across countries, however the causes and the ranges of variation are not well understood.

The causes of the infections are not as high as would be assumed on the surgical procedure, but co-morbidity and lifestyle choices including alcohol consumption may exacerbate risk. As Dr Edmiston states, there are a myriad of causes, and funding is limited in many countries. However there are some solutions, where goals, performance tracking against the goals and better communication is needed.

Global effort to reduce postoperative infection risk

Infection rates following surgical procedure vary across countries, however the causes and the ranges of variation are not well understood.

The causes of the infections are not as high as would be assumed on the surgical procedure, but co-morbidity and lifestyle choices including alcohol consumption may exacerbate risk. As Dr Edmiston states, there are a myriad of causes, and funding is limited in many countries. However there are some solutions, where goals, performance tracking against the goals and better communication is needed.

Transformative AI in a COVID World

urrently working back in the clinic as a pediatric cardiologist after a year in telehealth, Dr Anthony Chang is investigating the short and medium impacts of COVID-19. Another area of focus is using AI, “Swarm Learning” and other technologies to share pediatric cardiology information, such as electronic records or images across health systems in the US and across other countries.
The International Council of Nurses represents the 27 millions nurses across 130 national nursing associations right around the world.

Supporting nurses doing extraordinary things

In a far reaching Global Health talk with Michael Lesner, International Council of Nurses CEO Howard Catton, speaks about the changing image of nurses over recent years. He joined as CEO to debunk the myths.

The International Council of Nurses represents the 27 millions nurses across 130 national nursing associations right around the world.

Scroll to top